Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TSC22D2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ASAH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CFAP70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COLGALT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCPH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RSRC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DUSP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf60 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF559-ZNF177 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIRIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EGFEM1P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM80 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RMDN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on